Viewing Study NCT03531905

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:31 AM
Ignite Modification Date: 2026-03-09 @ 8:17 AM
Study NCT ID: NCT03531905
Status: COMPLETED
Last Update Posted: 2020-04-09
First Post: 2018-05-09
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C
Sponsor: Esperion Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes View
None Diabetes Mellitus, Type 2 View
None Cholesterolemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None diabetes View
None cholesterolemia View
None type 2 diabetes View
None LDL-C View
None T2D View
None diabetes mellitus View